Lv73
4710 积分 2024-12-29 加入
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
25天前
已完结
Intestinal Ultrasound and Magnetic Resonance Imaging for Monitoring Therapeutic Response in Luminal Crohn's Disease. A Systematic Review
1个月前
已完结
Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting
1个月前
已完结
Crohn’s disease
2个月前
已完结
Inflammation and malnutrition in inflammatory bowel disease
3个月前
已完结
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
3个月前
已完结
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
3个月前
已完结
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial
5个月前
已完结
Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial
5个月前
已完结
Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial
5个月前
已完结
皖公网安备34019202002308
